Skip to main content
Camilo Jimenez, MD, Endocrinology, Houston, TX

Camilo Jimenez MD

Diabetes, Lipid Metabolism


Physician

Join to View Full Profile
  • 1515 Holcombe BlvdHouston, TX 77030

  • Phone+1 713-792-6161

Dr. Jimenez is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Baylor College of Medicine
    Baylor College of MedicineFellowship, Endocrinology, Diabetes, and Metabolism, 2001 - 2004
  • University of Miami/Jackson Health System
    University of Miami/Jackson Health SystemResidency, Internal Medicine, 1998 - 2001
  • Pontifical Xavierian University
    Pontifical Xavierian UniversityClass of 1995

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • TX State Medical License
    TX State Medical License 2007 - 2027
  • Endocrinology, Diabetes and Metabolism
    American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Pheochromocytoma and Paraganglioma: Perioperative, Management, Surveillance, and New Imaging Modalities (Repeat) 
    ENDO 2019 - New Orleans, LA - 3/23/2019
  • Clinical Management of Adrenocortical Carcinoma 
    ENDO 2019 - New Orleans, LA - 3/24/2019
  • Adrenal Tumors and Hyperplasia 
    ENDO 2019 - New Orleans, LA - 3/24/2019
  • Join now to see all

Press Mentions

  • Lantheus Announces Presentation Featuring AZEDRA® (Iobenguane I 131) at ENDO 2021
    Lantheus Announces Presentation Featuring AZEDRA® (Iobenguane I 131) at ENDO 2021March 22nd, 2021
  • MD Anderson Research Highlights for April 24, 2024
    MD Anderson Research Highlights for April 24, 2024April 25th, 2024
  • Cabozantinib Promising for Metastatic Pheochromocytomas, Paragangliomas
    Cabozantinib Promising for Metastatic Pheochromocytomas, ParagangliomasApril 30th, 2024

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: